missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human MLSTD2 (aa 7-149) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (96%), Rat (96%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53585 (PA5-53585. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
MLSTD2 catalyzes the reduction of saturated fatty acyl-CoA with chain length C16 or C18 to fatty alcohols.
Specifications
Specifications
| Accession Number | Q8WVX9 |
| Concentration | 3.50 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 84188 |
| Name | Human MLSTD2 (aa 7-149) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2600011M19Rik; 2900034E22Rik; 3732409C05Rik; AI850429; FAR1; fatty acyl CoA reductase 1; fatty acyl-CoA reductase 1; male sterility domain containing 2; male sterility domain-containing protein 2; MLSTD2; PFCRD; SDR10E1; short chain dehydrogenase/reductase family 10 E, member 1; UNQ2423/PRO4981 |
| Common Name | MLSTD2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction